An asymmetric synthetic route to 2-substituted-3-aminocarbonyl propionicacid, which is the significant component of low-molecular-weight renin inhibitors, is described. The key step of this synthesis is diastereoselective alkylation by using chiral oxazolidinone and benzyl bromoacetate.